Cruinn Diagnostics Acquired Katalyst Diagnostics
The deal expands Cruinn's market presence in the UK and provides access to new NHS clinical customers.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Do you believe industry mergers and acquisitions generally lead to better service for customers?
Cruinn Diagnostics has acquired Katalyst Diagnostics to strengthen its footprint in the UK market. The strategic move grants Cruinn access to established NHS relationships and a range of point-of-care diagnostic solutions.
Why it matters
This acquisition allows Cruinn to leverage an established Irish platform while tapping into the UK healthcare sector. The move is designed to integrate complementary diagnostic offerings to better serve clinical clients.
The combined group now employs more than 100 people and generates annual revenues exceeding €50 million. Management has set a long-term target to grow the combined group to €150 million in revenue.
The players
Cruinn Diagnostics
This diagnostic solutions company is based in Ireland and serves as an established platform for growth.
Katalyst Diagnostics
This firm provides point-of-care diagnostic solutions and serves clinical customers and the NHS in the UK.
Afsheen Khan
She serves as the managing director of Katalyst Diagnostics and will continue in her leadership role.
The details
Katalyst Diagnostics will continue to operate under its existing leadership, with Afsheen Khan remaining as managing director. Cruinn intends to utilize its Irish operations to support the continued growth of the combined portfolio.
Timeline
September 24, 2026: The acquisition was formally announced.
Market Landscape
This acquisition aligns with the broader trend of consolidation within the European medical diagnostics market as firms seek to scale operations. The deal strengthens Cruinn's competitive position against larger international players by expanding its service capacity and geographic reach.
The integration of these diagnostic firms aims to streamline service delivery for NHS and clinical customers. Patients and healthcare providers may see improved access to a broader portfolio of diagnostic tools as the combined group scales its operations.
The takeaway
The merger highlights the importance of scaling operations to meet rising diagnostic demand in the UK. Future growth remains a priority for the firm as it looks toward potential expansion into continental European markets.
Further reading
Learn more about the latest developments in the sector at Healthcare.
Source note: This article includes information reported by Business Plus.
Live Poll
Do you believe industry mergers and acquisitions generally lead to better service for customers?
